The International Society for Pharmacoepidemiology (ISPE) seeks proposals for manuscripts that could be used for guideline development, or reference documents for pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.
For a list of ISPE Endorsed Manuscripts click here
|
This year, highest consideration will be given toward the following new topics: |
|
|
|
|
|
|
ISPE is also interested in emerging issues, best practices & guidance for methods in pharmacoepidemiology covering the following topics: |
|
|
|
|
|
|
|
|
Proposals are reviewed by a Joint Manuscript Proposal Review Subcommittee led by the chair of the Public Policy Committee. The final slate of papers recommended for funding is ratified by the Executive Committee. Once funding is approved, manuscript writing teams can begin work. When a draft is ready, papers are submitted via the Executive Office for Public Policy Committee evaluation for suitability for ISPE member review. Periodically, writing teams are required to submit progress reports for Board evaluation.
Proposals must conform to the format described in this document.
Submissions for 2024, which may only be submitted online, are now being accepted here with a deadline of 11:59 PM US Eastern Time on Tuesday, October 1, 2024. Proposals must conform to the proposal format described in this document. Proposals that do not conform to the format will not be considered for funding. The deadline will not be extended, and proposals submitted via other means will not be accepted.
Oct 1 – Submission deadline
Oct 31 – Joint Manuscript Proposal Review Subcommittee completes first review; if applicable, feedback is provided to writing teams and revised proposals requested
Nov 22 – If applicable, author responses to feedback due back to ISPE
Dec 16 – Joint Manuscript Proposal Review Subcommittee makes final selections; notifications to writing team lead contact
